http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001039847-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd727aa2b4e6c347aadd94971881d671
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
filingDate 1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68f4e819e272ddc1e3d2302339e5da8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80089fd67d3618ce604080bb7e7e4f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0977a7df4a8f9f3a00c12c61221c8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b7a486cad02784254c338b8c25c2ea0
publicationDate 2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2001039847-A
titleOfInvention External composition for skin
abstract (57) [Summary] PROBLEM TO BE SOLVED: To provide a composition for external use on the skin, in particular, a composition for external use on the eyes, which is capable of correcting darkness around the eyes and dullness of the skin, and further improving darkness and dullness. I will provide a. SOLUTION: In the Munsell color system, the hue (H) of the interference light has spectral reflectance characteristics belonging to the P, RP, R, YR, Y regions (purple to yellow), and the surface is coated with iron oxide. One or two or more of the interference-type iron oxide-coated mica titanium and one or more of the blood circulation promoters are blended.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016155902-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168209-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004315390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003012459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005350407-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002087926-A
priorityDate 1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID180772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421227023
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID180772
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456486130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407377111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14488
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394161
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID137129
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID137129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519949
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID32247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID32247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518696

Total number of triples: 54.